Qiagen NV announced that Prof. Dr. Dr. h.c. Detlev Riesner, a co-founder and Chairman of the Supervisory Board, retired on May 5, 2014, as Chairman of the Supervisory Board after having served as a member of the Board since 1996 and as Chairman since 2003. As previously announced, he has decided not to stand for re-election at the Annual General Meeting scheduled for June 25, 2014. Dr. Werner Brandt has been selected by a Joint Meeting of the Supervisory Board and Managing Board to become the new Chairman of the Supervisory Board.

Dr. Brandt, who has more than 30 years of leadership experience in the healthcare and IT industries, joined the Supervisory Board in 2007 and was appointed the same year as Chairman of the Audit Committee. He is also retiring in 2014 as a member of the Executive Board of SAP AG. Prof. Dr. Elaine Mardis is being proposed for election as a new member of the Supervisory Board at the next Annual General Meeting.

Dr. Mardis, an internationally recognized expert in the development of DNA sequencing technologies and bioinformatics, is a Co-Director of The Genome Institute at Washington University in St. Louis, Missouri.